amantadine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia Gil, M; Sanchez Crespo, M | 1 |
| Banerjee, A; Eckels, PC; England, KM; Gamboni-Robertson, F; Gries, LM; Kelher, MR; Khan, SY; McLaughlin, NJ; Moore, EE; Silliman, CC | 1 |
2 other study(ies) available for amantadine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine | 1983 |
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.
Topics: Amantadine; Antigens, CD1; Clathrin; Endocytosis; Enzyme Activation; Humans; In Vitro Techniques; NADPH Oxidases; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Rimantadine; Signal Transduction | 2009 |